Apatinib Treatment for Advanced Esophagus Cancer
Subject ever received a standard chemotherapy solution progression or recurrence or can't tolerate chemotherapy with advanced esophageal squamous carcinoma.
Advanced Esophagus Cancer
DRUG: Apatinib
Progress free survival, Time subject into the group to tumor objective progression., 24 months
Overall survival, Time subject into the group to die., up to 24 months
Subject ever received a standard chemotherapy solution progression or recurrence or can't tolerate chemotherapy with advanced esophageal squamous carcinoma.